Combination of the toll like receptor agonist and α-Galactosylceramide as an efficient adjuvant for cancer vaccine

BACKGROUND: DNA vaccines have emerged as an attractive approach for the generation of cytotoxic T lymphocytes (CTL). In our previous study, we found That Toll like receptor (TLR) ligands are promising candidates for the development of novel adjuvants for DNA vaccine. To improve the efficacy of DNA v...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Biomed Sci
Asıl Yazarlar: Gableh, Fateme, Saeidi, Mohsen, Hemati, Shaghayegh, Hamdi, Kasra, Soleimanjahi, Hoorieh, Gorji, Ali, Ghaemi, Amir
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2016
Konular:
Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4727273/
https://ncbi.nlm.nih.gov/pubmed/26811064
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-016-0238-3
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller